EFFECTS OF N-NITROSODIBUTYLAMINE ON THE LIVER MITOCHONDRIA MORPHOLOGY AND ON THE EXPRESSION OF LIVER MITOCHONDRIAL MEMBRANE SURFACE PROTEINS IN MICE. by Dutta, Sthiti Porna et al.
 
Original Article 
EFFECTS OF N-NITROSODIBUTYLAMINE ON THE LIVER MITOCHONDRIA MORPHOLOGY AND 
ON THE EXPRESSION OF LIVER MITOCHONDRIAL MEMBRANE SURFACE PROTEINS IN MICE 
 
STHITI PORNA DUTTA, ROBIN PATNAIK JAMIR, STEPHANIE PAULA BASAIAWMOIT, ANIS ALAM 
Department of Biochemistry, Immunology laboratory, North-Eastern Hill University, Shillong 793022, Meghalaya, India 
Email: sthitidutta7@gmail.com  
 Received: 04 Feb 2016 Revised and Accepted: 15 Mar 2016 
ABSTRACT 
Objective: N-Nitroso-dibutyl amine (DBN) is an established hepatocarcinogen in rodents and its effects on the liver of Swiss albino mice have been 
examined. The observed alteration in marker enzymes activities indicates hepatic dysfunction and damage to the liver caused by DBN-treatment in 
mice. This study was aimed to check the carcinogenic effects of DBN exposure on liver mitochondria. 
Methods: DBN at a dosage of 10 mg kg-1 body weight in 5 % ethanol was administered intravenously weekly for a period of 16 w to induce cancer. 
Cancer induction was followed by monitoring the activities of marker enzymes such as acetylcholine esterase (AChE), glutathione-S-transferase 
(GST) and gamma-glutamyl transpeptidase (GGT), which was further supported by the histological examination of liver tissue. Transmission 
electron microscopy was done to see the alterations in the morphology of the liver mitochondria. Liver mitochondrial membrane proteins were 
isolated, and proteomic analysis was done. 
Results: Our preliminary observations indicated significant alterations in the activities of liver marker enzymes [GGT and AChE significantly 
elevated (<0.025 and<0.0001) whereas GST significantly decreased<0.0001] and in the morphology of liver mitochondria in mice upon DBN 
exposure. The shape and size of liver mitochondria were found to be highly disrupted and contained large vacuoles, enlarged cristae compartments 
in comparison to that of the normal control mice. The protein concentration was significantly elevated (<0.0001) in treated mice. The proteomic 
analysis of the liver mitochondrial membrane surface proteins showed differential expression in DBN-treated mouse compared to that of the 
normal control. A protein of approximately 14 kDa was found to be overexpressed in the case of DBN treated mice which was seen in a trace amount 
in normal control. Overexpressed protein was found to be anionic in character.  
Conclusion: It was evident from the present study that a weekly dosage of DBN with 5 % ethanol for 16 w induces hepatocarcinoma in mice. These 
results suggested that alterations in the morphology of mitochondria, differential expression of mitochondrial proteins upon DBN exposure are 
associated with mitochondrial dysfunction in the liver. 
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INTRODUCTION 
Exposure of humans to nitrosamines or to their precursor 
compounds is associated with high risks of cancer. Nitrosamines are 
chemical compounds most of which are carcinogenic. N-Nitroso-
dibutyl amine (DBN) is a class of nitrosamine, which is reasonably 
anticipated to be a human carcinogen based on sufficient evidence of 
carcinogenicity in experimental animals [1]. DBN possess the ability 
to induce bladder tumor as well as in the liver esophagus when it is 
administered orally [2]. It was hypothesized that O-6 alkylation of 
guanine leads to the inability of the guanine residue to undergo 
normal base pairing with cytosine and thus may lead to “transition” 
mispairing, resulting in mutation [3]. Carcinogenesis can be 
enhanced with relatively low daily doses of ethanol. Ethanol is not a 
carcinogen, but under certain experimental conditions is a co-
carcinogen and/or (especially in the liver) a tumor promoter [4]. A 
study where high amounts of alcohol were given to mice suggests 
that it accelerates their cancer growth by speeding up the loss of 
body fat and depressing immune activity [5].  
Mitochondrial defects have long been suspected to play an 
important role in the development and progression of cancer [6]. 
Considering that most tumor cells were resistant to apoptosis, so 
such resistance might relate to the particular properties of 
mitochondria in cancer cells that were distinct from those of 
mitochondria in non-malignant cells. Mitochondrial dysfunction in 
the tumor was first observed in 1926 by Otto Warburg. Warburg 
hypothesis postulates that tumorigenesis was driven by an 
insufficient cellular respiration which was due to the defect in 
mitochondria [7]. In addition, local acidification of the tumor 
microenvironment may facilitate tumor invasion [8]. 
Mitochondria play an important role in apoptosis. Mitochondria 
from cancer cells were often resistant to the induction of 
mitochondrial outer membrane permeabilization (MOMP), a 
process which mediates the intrinsic pathway of apoptosis [9, 10]. 
MOMP is an extremely complex phenomenon that is regulated by 
proteins from the Bcl-2 family [11], proteins contained in the 
permeability transition pore complex [12], proteins that affect 
mitochondrial dynamics (fusion and fission) [13, 14] and even 
transcription factors (such as the tumor-suppressor protein p53) 
that can translocate from the nucleus to mitochondria to stimulate 
MOMP [15]. Mitochondria were affected early in the apoptotic 
process and are now thought to act as central coordinators of cell 
death [16].  
Warburg suggested that cancer is caused by damage of 
mitochondria. A number of additional metabolic alterations 
associated with mitochondrial function have been observed in 
cancer cells, including increased gluconeogenesis [17], reduced 
pyruvate oxidation and increased lactic acid production [18], 
increased glutaminolytic activity [19], and reduced fatty acid 
oxidation [20]. The activities of certain enzymes integral to the 
process of oxidative phosphorylation are known to be decreased in 
cancer versus normal cells. For example, the measured maximal 
velocity for ATPase activity in mitochondria [21] and 
submitochondrial particles [22-24] isolated from hepatocellular 
carcinoma is considerably lower than that in normal liver.  
Targeting the mitochondria appears to be a promising strategy for 
the search of novel anticancer treatment as well as the drugs. The 
potential of this field may be utilized in the identification of new 
markers and risk assessment as well as therapeutic targets. 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                 Vol 8, Issue 5, 2016 
Dutta et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 5, 162-168 
 
163 
MATERIALS AND METHODS 
Materials 
N-Nitroso dibutyl amine (DBN), Acetylcholine chloride, Acrylamide, 
Albumin bovine, Ammonium persulphate (APS), Brilliant Blue G, 
5,5’-dithiol bis-(2-nitrobenzoic acid) (DTNB), Ethylene diamine 
tetraacetic acid (EDTA), L-γ-Glutamyl-p-nitroanilide, Glycylglycine, 
2-Mercaptoethanol, N,N’-Methylene bisacrylamide, Polyoxyethylene 
sorbitan monolaurate (Tween 20), CM-Sephadex C50, Sodium Lauryl 
Sulphate (SDS), N,N,N’,N’-Tetramethyl ethylene diamine (TEMED), 
Triton-X-100, Trizma base [tris-(hydroxymethyl)-aminomethane] 
were obtained from Sigma Chemical Co., USA. Protein Molecular 
weight markers, Bromophenol Blue, DPX, Eosin 2%, Glycine, 
Hematoxylin, Coomassie Brilliant Blue R-250, 1-Chloro-2, 4-dinitro 
benzene (CDNB), Ethanol and all other chemicals were of analytical 
grade procured from various indigenous sources.  
Animals 
Swiss Albino female mice of around 6 to 8 w old were (BALB/c) used 
in the experiment was procured from the Pasteur Institute Shillong. 
Animals were bred at the animal house of the department by 
random inbreeding and were kept on basal diet ad libitum and 
housed in plastic cages in a temperature controlled animal room 
(21±2 °C) with a 12 h light and dark cycle. The mice weighed 25-27 g 
at the start of the experiment. All animal procedures were 
performed according to approved protocol and in accordance with 
recommendations for the proper use and the care of the laboratory 
animals. The protocols were approved by Institutional Ethics 
Committee (Animal models) on a meeting held on 21st April 2014 at 
North Eastern Hill University, Shillong, Meghalaya-22. 
Cancer induction 
A weekly dose of 10 mg kg-1 body weight of DBN in 5% ethanol was 
prepared and administered intravenously in healthy female mice of 
6-8 w old for a period of 16 w. Animals were divided into two 
groups. 
Group 1: Normal control, Age-matched healthy female mice. 
Group 2: Treated, DBN in 5% ethanol (10 mg kg-1 body weight).  
Mice were sacrificed at the end of treatment as required. All treated 
mice were checked for carcinogenesis by monitoring the activities of 
liver marker enzymes such as acetylcholine esterase (AChE), 
glutathione-S-transferase (GST) and gamma glutamyl 
transpeptidase (GGT). Hepatocarcinomas were confirmed by the 
histological examination of liver tissue from the treated mice. The 
variations in the body weight and other morphological changes from 
the 8th week onwards during the study period were recorded for 
both the groups at regular interval of 2 w till the 16th week. Age-
matched sham-treated mice served as control. 
Tissue preparation for enzymatic assay 
After completion of treatment, the mice were killed by cervical 
dislocation and the liver was excised and removed quickly, rinsed in 
ice-cold normal saline (0.9% Sodium chloride), blotted dry and 
weighed. A 10% homogenate was then prepared in chilled 0.25 mol 
sucrose solution and centrifuged at 20,000 x g for 30 min at 4 ˚C. The 
resulting supernatant was used for enzyme assays using modified 
procedure as described earlier [25]. Total protein content was 
estimated by Bradford method [26]. 
Marker enzyme assays 
Gamma-glutamyl transpeptidase (GGT), Acetylcholine esterase 
(AChE) and Glutathione S-transferase (GST) activities assays were 
carried out by the methods described [27-29] respectively with 
slight modifications as described earlier [25]. 
Preparation of histological sections 
For histological examination of the liver tissues from DBN treated 
and normal mice microtome technique was used. In brief liver 
tissues were fixed in Bouin’s solution. Tissues were washed 
thoroughly under running tap water. Dehydration was carried by 
placing tissues in an increasing alcoholic grade from 30% to 100%. 
Ethanol was cleared by placing the tissue in xylene. Tissues were 
embedded in paraffin wax. Blocks were prepared, trimmed and the 
ribbon was cut and mounted on slides, dried, and the wax was 
removed by xylene followed by rehydration with alcohol by 
reducing concentration from 100% to 30%. Slides were stained with 
hematoxylin and eosin, and again dehydration was done with 90% 
and 100% ethanol. A drop of DPX was placed on the slide and cover 
slip was placed over it. After two days of drying, slides were 
examined microscopically. 
Transmission electron microscope (TEM) studies of liver 
mitochondria  
Protocol for preparation of the sample was obtained and 
standardized by sophisticated analytical Instrumentation Facility 
(SAIF) laboratory in NEHU [30]. 
Isolation of mitochondria 
Intact liver mitochondria were isolated from mice by the method 
described [31] with some modification. In brief, the mouse was 
starved overnight before the experiment. Mice were killed by 
cervical dislocation, and liver was rapidly excised and washed with 
ice-cold isolation buffer and was minced 0.5 ml of isolation buffer 
was added to the minced liver and homogenized. Homogenate was 
then centrifuged at 600 x g at 4 ˚C for 10 min. Supernatant was 
collected and again centrifuged at 7000 x g for 10 min at 4 ˚C. 
Supernatant was discarded, and the pellet was re-suspended in 5 ml 
of isolation buffer and centrifuged for 10 min at 4 ˚C at 7000 x g. 
Supernatant was discarded, and the pellet containing mitochondria 
was re-suspended and stored on ice. 
Isolation of mitochondrial membrane protein 
Mitochondrial membrane protein was extracted by the method 
described by Frilabo [32] with slight modifications. In brief, isolated 
mitochondria was re-suspended in 1/3 packed cell volume of lysis 
buffer. The suspension was homogenized with 0.5% Tween 20 and 
0.5 mol potassium chloride (KCl). The mitochondrial lysate was then 
spun at 100 000 x g in ultracentrifuge at 4 ˚C for 1 h. Supernatant 
containing the membrane protein was collected carefully and stored 
at-80 ˚C. Total protein concentration was estimated by Bradford 
method [26]. 
Extraction of mitochondrial membrane surface protein 
The mitochondrial membrane protein extracts were subjected to 
SDS-PAGE (15%) analysis with a protein molecular weight marker 
containing proteins of molecular weight ranging from 43 kDa to 3 
kDa. The gel was run at a current of 60 mA using Mini-PROTEAN 
Electrophoresis Cell from BioRad. The gels were stained with 
coomassie brilliant blue.  
Purification of mitochondrial protein and its SDS-PAGE analysis 
CM-Sephadex C50 were swollen overnight in the phosphate buffer 
(pH 6.5), packed into the column and was equilibrated with the 
buffer overnight. Mitochondrial protein extract was then loaded 
onto the Sephadex column. The unbound proteins were eluted with 
the phosphate buffer for 1 h. Bound proteins were then eluted with a 
salt gradient of 0 to 100 mM sodium chloride in the same buffer for 
1h. Fractions collected were measured at an absorbance of 280 nm. 
The fractions corresponding to the peak in the unbound region 
obtained from cation exchanger were subjected to run SDS-PAGE for 
the profiling. 
Preparative SDS-PAGE analysis of unbound proteins 
The fractions corresponding to the peak in the unbound region 
obtained from cation exchanger were subjected to run on 
preparative SDS-PAGE for final purification of the desired protein. A 
longitudinal section of the gel corresponding to the crude extract 
lane was cut and stained which was used as a reference to locate the 
exact position of the TAA in the rest of gel. The portion of the gel 
corresponding to the TAA was cut out of the unstained gel. It was cut 
into small pieces and homogenized in 3% 1-butanol. The 
homogenate was centrifuged at 8000 x g for 30 min at 4˚C. The 
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supernatant was collected and the pellet was collected and the pellet 
was re-suspended in 3% 1-butanol and centrifuged. The supernatant 
collected was pooled, dialyzed against distilled water overnight and 
lyophilized. It was then run on an SDS-PAGE gel for homogeneity of TAA. 
Statistical analysis 
All the values are expressed as mean±SEM. Statistical analysis was 
carried out using Graph Pad Prism.  
RESULTS 
After 16 w of complete treatment some physiological and 
morphological changes were seen in DBN treated mice. DBN treated 
mice were seen to more lethargic accompanied with weight loss as 
compared to those of control as shown in table 1. The weight of the 
normal mice was found to more than treated mice. 
However, when liver was excised significant morphological changes 
were seen in the liver from DBN treated mice (fig. 1). Liver from 
DBN treated mice was found to be enlarged and weighed more than 
the liver from control mice (table 1). Liver tissues of DBN treated 
mice were seen to be swollen and had hardened as shown in (fig 1). 
White patches and nodule formation were also seen in treated mice 
which were absent in normal age-matched mice. 
Histological examination of the liver 
Liver tissues of DBN treated mice, and normal control age-matched 
mice were examined microscopically at a magnification of 40x (fig. 
3). Significant morphological changes were seen in the liver cells 
following DBN treatment upon comparison with age-matched 
normal control mice. When compared liver tissues cells of control 
mice were found to be in regular morphology, cell to cell contact was 
seen. Hepatocytes in normal mice had well-defined outlines with 
mono and bi-nucleated cells. In the cell of the liver tissues of treated 
mice no regular morphology was seen, cells showed variations in 
shape and size. Loss of cell to cell contact. Most of them were seen 
having an irregular outline and to be multinucleated. 
 
Table 1: Weight of mice and mice liver 
Sample  Mice (g)  Liver (g) 
Control  32.3±0.210 0.7±0.112 
Treated 26.1±0.298**** 1.1±0.033** 
Each value shows mean±SEM; n=10. ****p<0.0001 denotes when the weight of control mice compared with treated mice; **p<0.0030 when the 
weight of the control liver was compared with treated liver.  
 
 
Fig. 1: Mouse liver photographs (a) Normal control mice (b) N-Nitrosodibuytlamine (DBN) treated mice. Swelling and nodules were 
observed in the liver excised from DBN treated mice 
 
 
Fig. 2: 2a Gamma-glutamyl transpeptidase (GGT) activity assay. The values in the bars are expressed as mean±SEM; n=10. *p˂0.025 when 
control was compared to treated. 2b Acetylcholine esterase (AChE) activity assay. The values in the bars are expressed as mean±SEM; 
n=10. ****p˂0.0001 when control was compared to treated. 2c Glutathione S-transferase (GST) activity assay. The values in the bars are 
expressed as mean±SEM; n=10. ****p˂0.0001 when control was compared to treated 
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Fig. 3: Microphotographs of the histological section at 40x of liver from (a) normal control mice and (b) N-Nitrosodibutylamine (DBN) 
treated mice showing distorted and multinucleated cells. The slides were stained with hematoxylin and eosin. Slides were examined 




Fig. 4: Microphotographs of the liver mitochondria from normal control mice and N-nitroso dibutyl amine (DBN) treated mice at different 
magnification 2000x, 12000x, 15000x. (a) Mitochondrial population from treated mice at 2000x. (b) Mitochondrial population from 
normal mice 2000x. (c) Defragmented and denser cristae in treated mice at 12000x. (d) Normal mitochondria at 12000x. (e) Diffused 
membrane, larger vacuoles and deformed mitochondria in treated mice at 15000x. (f) Normal mitochondria at 15000x 
Dutta et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 5, 162-168 
 
166 
Isolation and morphological studies of the liver mitochondria  
Transmission electron microscopy of the mitochondrial 
morphology 
On comparing the micrographs obtained from TEM at various 
magnifications 2000x, 10000x, 15000x (fig. 4) significant changes 
were observed. Electron microscopy pictures revealed that 
mitochondria were barely identifiable in the case of DBN treated 
mice. It was found that most of the mitochondria from DBN treated 
mice had distorted and looked like remnants (fig. 4b). Mitochondria 
showed variability in number (fig. 4a and 4b), size and shape (fig. 4c 
and 4d). The cristae membranes had greatly reduced and 
disorganized in the case of the treated mice whereas in normal mice 
they looked normal and organized. Cristae appeared denser and 
mitochondrial fragmentation was seen in treated mice.  
The inner and outer membrane of the mitochondria was found to be 
disrupted, and most of the mitochondria were condensed. They 
were found to have larger vacuoles whereas the mitochondria in 
control mice showed no such changes. They had well-defined 
membrane along with normal vacuoles. 
Total mitochondrial protein concentration 
Total mitochondrial protein concentration in treated mice was estimated 
using Bradford method. The protein content was found to be 
significantly higher in DBN treated mice than in control mice (fig. 5). 
 
 
Fig. 5: Total mitochondrial membrane surface protein 
estimation. The values in the bars are expressed as mean±SEM; 
n=10. ****p<0.0001 when control compared with treated 
 
 
Fig. 6: SDS-PAGE analysis of the extracted mitochondrial 
membrane surface protein obtained from N-Nitrosodibutylamine 
(DBN) treated mice and normal control mice. A gel consisting of 
15% (w/v) acrylamide was used for running the sample. Gel was 
stained using Coomassie blue and destained with methanol, 
acetic acid and water (4:1:5). Lane (a) Low weight molecular 
marker, Lane (b) Medium weight molecular marker, Lane (c) 
DBN treated extract and Lane (d) Normal control mice. A protein 
of approximately 14 kDa was seen to be overexpressed in the 
lane 3 containing DBN treated extract 
SDS-PAGE analysis of the isolated mitochondrial membrane 
protein and identification of the tumor-associated antigens (TAA) 
SDS-PAGE analysis of mitochondrial membrane protein 
Mitochondrial membrane protein extracts from both normal and 
treated were analyzed on SDS-PAGE. Differential expression of 
proteins was seen in the liver mitochondrial membrane of treated 
mice. A protein of approximately 14 kDa was found to be 
prominently overexpressed in treated mice which were also found 
to be present in normal mice in trace amount (fig. 6). 
Purification of the TAA 
Cation exchange chromatography 
A cation exchanger CM-Sephadex C50 was used for the purification. 
The elution profile of the cation exchange chromatography is shown 
in (fig. 7). It was found that most of the proteins eluted out in the 




Fig. 7: CM-Sephadex C50 a cation exchange protein profile of the 
liver mitochondrial surface membrane protein from DBN 
treated mice 
 
SDS-PAGE analysis of purified protein 
SDS-PAGE analysis confirmed that the protein of interest was eluted 
out in unbound fraction shown in (fig 8). The protein was therefore 
confirmed to be anionic in character. A prominent band was 
observed in the lane loaded with the fractions of the unbound 
region. The identified band of protein was approximately found to 
be of 14 kDa, which was found to absent in the bound fractions 
region of the elution profile.  
 
 
Fig. 8: SDS-PAGE analysis of the unbound fractions obtained 
from the cation exchange column chromatography of the DBN 
treated extract. Lane 1 and 6: medium weight molecular 
marker, Lane 2 and 8: Low weight molecular marker, Lane 3 
and 7: Unbound fractions, Lane 4: DBN treated extract and Lane 
5: control 
 
Preparative SDS-PAGE for purification of the TAA 
As a single band couldn’t be obtained from the ion exchange 
chromatography, an additional purification step was carried out. 
The fractions corresponding to the peaks were pooled together, 
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dialyzed against distilled water, concentrated and further purified 
using preparative SDS-PAGE. The TAA recovered from the 
preparative SDS-PAGE was subjected to an SDS-PAGE gel and a 
single band corresponding to the 14 kDa protein was obtained as 
shown in the (fig. 9).  
 
 
Fig. 9: Preparative SDS-PAGE purified TAA. The portion of the 
gel corresponding to the TAA was cut out of the unstained gel. It 
was cut into small pieces and homogenized in 3% 1-butanol. 
The homogenate was centrifuged at 8000 g for 30 min at 4˚C. 
The supernatant collected was pooled and dialyzed. Lane 1: 
Purified TAA and Lane 2: DBN treated extract 
 
DISCUSSION 
Weekly intravenous administration of DBN (10 mg kg-1 body weight) 
in 5% ethanol up to a period of 16 w induced hepatocarcinogenesis 
in Swiss albino mice. Many changes such as hardening of the tissues, 
swelling, white patches, and formations of nodules were observed in 
liver from the N-Nitrosodibutylamine (DBN) treated mice which 
were not seen in any normal control mice (fig. 1). Reports available 
stated that the initiation of carcinogenesis is induced by nitrosamine 
upon its coupling with proliferative stimuli especially in the liver 
[33]. From these results, it seems likely that cancer initiating events 
involves some form of carcinogen-DNA interaction leading to 
multiple alterations in structure and functions of the normal cells. 
Initiation of carcinogenesis is usually accompanied by the abnormal 
production of the enzyme, proteins, and hormones. Carcinogenesis 
induction in mice in the present investigation was confirmed by 
monitoring the activities of enzyme markers i.e. GGT, AChE, and GST. 
GGT activity was significantly found to be higher in treated mice as 
compared to that of normal control mice (fig. 2a). The GGT 
expression was interpreted as an early marker of neoplastic 
transformation. In liver, GGT activity has been recognized as a 
positive and sensitive marker for the diagnosis of hepatocellular 
transformation [34]. It has been widely used as a marker in 
preneoplastic lesions in the liver during chemical carcinogenesis 
[35]. Since carcinogenesis is accompanied by changes in the 
membrane, so assay of AChE was chosen as second marker enzyme 
as it is a membrane-bound enzyme. Liver tissues of the treated mice 
showed a higher activity of AChE than the normal control (fig. 2b). 
Elevation in the activity of AChE has been related to changes in the 
membrane of the liver cells and also served as evidence for loss of 
membrane integrity [36]. The activity of GST was found to lesser in 
DBN treated mice when compared to that of normal age-matched 
mice (fig 2c). GST is known as detoxification enzyme, and a decrease 
in the activity of this enzyme showed the acceleration in the 
pathogenesis of liver cancer [37]. The decrease in GST activity in 
DBN-treated mice signifies that it leaves the cell vulnerable to these 
agents. These observed changes in marker enzymes activities are in 
accordance with earlier findings [25].  
Histological studies were done for the verification and for 
monitoring the success of cancer induction. Many changes were 
observed when the histological liver sections from treated and 
normal were compared. Liver cells in DBN treated mice were found 
with poorly defined cell boundaries, irregularity in sizes and shapes, 
the absence of a cell to cell contact. Most of the cells were found to 
be multinucleated, and nuclei appeared to be more densely stained 
which may be due to condensed chromatin. Whereas the liver cells 
of normal mice did not show any such changes and most of the cell 
had well-defined morphology and found to be single or binucleated 
(fig. 3). The observed morphological changes further indicated that 
cells are in a state of rapid division, loss of functions and supported 
the progression of cancer induction.  
The main target of the present investigation was to see whether 
DBN effects the liver mitochondria and its surface membrane 
protein or not. Transmission electron microscopy allows seeing the 
mitochondrial morphology and their overall organization. So to see 
the morphological changes TEM was done. Intact mitochondria 
isolated from the liver of both treated and control mice were 
observed microscopically. A drastic distortion in shape and size and 
abnormalities in the population of mitochondria was observed in the 
present study (fig. 4). Mitochondria from the treated mice appeared 
to bigger in size than from the normal. It was reported in the studies 
that mitochondria are barely identifiable in hepatocellular 
carcinoma, and looked like mitochondrial ghosts [38]. The cellular 
function of mitochondria is reflected in their structure [39]. Defects 
in mitochondrial function have been suspected to play an important 
role in the development and progression of cancer [40, 41]. Highly 
disrupted membrane and large vacuoles were seen in treated mice. 
Enlarged, denser and distorted cristae compartments were also 
found in DBN treated mice which were seen in regular and normal 
condition in normal mice. The mitochondrial swelling with 
distortion of the cristae was found to be associated with hypoxic–
ischemic conditions [42]. It’s been reported that mitochondrial 
swelling with partial or total cristolysis suggests that the ability of 
neoplastic cells to generate ATP by mitochondrial oxidative 
phosphorylation would be diminished [43]. Studies have shown that 
mitochondrial morphology is crucially linked to energy metabolism 
resulting enhanced respiration which correlates with an enlarged 
cristae compartments and interconnected network [44]. 
Mitochondria from the treated mice seemed to be diffused and 
fragmented. It has been showed in studies that mitochondria from 
the liver tumors were more fragile than from the normal liver 
mitochondria [45]. Mitochondrial fragmentation is the result of 
excessive fission, and small punctuate mitochondria can be derived 
from mitochondrial fission [46]. Fragmentation of the mitochondrial 
network appears to occur in those situations where the mitochondrial 
inner membrane potential was abnormal [47] and was in response to 
oxidative phosphorylation impairment [48]. The fragmentation of 
mitochondria does not found to evoke apoptosis [46]. 
An attempt was also made for proteomic analysis of the liver 
mitochondrial membrane surface proteins in DEN-treated animals. 
The SDS-PAGE analysis of liver mitochondrial membrane protein 
extract showed differential expression of surface membrane 
proteins in mice upon DBN exposure as compared to that of the 
normal control (fig. 6). Several proteins were found up-regulated or 
over-expressed upon comparison with the normal. The observed 
alteration in protein expression clearly indicated that DBN has 
inflicted major changes in the membrane of mitochondria. These 
changes could be involved in causing distortions and alterations of 
the mitochondrial membrane during DBN treatment. The protein of 
interest was found to be anionic in character. 
CONCLUSION 
From the present study, it can be concluded that a weekly dosage of 
10 mg kg-1 body weight of DBN in 5 % ethanol by intravenous 
administration induces hepatocarcinogenesis. Morphological 
changes in the liver tissue, marker enzyme activities of the DBN 
treated mice as well as the histological examination of the liver from 
the DBN treated mice clearly indicated that the hepatocytes were in 
the preneoplastic stage.  
Significant changes in the morphology of the mitochondria and on 
the expression of the mitochondrial protein from the DBN treated 
mice suggested that specific mitochondrial proteins were uniquely 
susceptible to alterations in the expression on DBN exposure and 
carry the potential as therapeutic and prognostic markers. From the 
above findings, we concluded that DBN exposure does not only 
affect the liver but also brings out morphological and functional 
changes in mitochondria and knowledge of such mitochondrial 
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proteins as those shown in the present study could be used to 
induce an immune response in cancer immunotherapy for 
eliminating the cancer cells those bear these antigens.  
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